We may accept, reject, limit, place on hold, or cancel an order before shipment, including for inventory issues, pricing errors, suspected fraud, regulatory concerns, suspected prohibited use, incomplete verification, payment problems, or shipping restrictions
First, there is no human clinical trial of AHK-Cu by any route injectable or topical and the entire peer-reviewed evidence specific to this peptide is a single 2007 study that was ex vivo (isolated human hair follicles) and in vitro (cultured dermal-papilla cells) [1]
They made it very easy to use, even for beginners
GLP-compliant testing is the standard required for data submitted to regulatory agencies to support safety or efficacy claims
Treatment should be initiated with parenteral hydroxocobalamin without delay in cases of cobalamin C defect, as in any suspected remethylation disorder, because it significantly improves survival and incidence of severe complications (101)
PubMed laboratory research record [PMID: 18199095] PubMed record related to this compound for laboratory literature review